Federico G. Baudou , María Herrera , Mariángela Vargas , Mauren Villalta , Florencia S. Conti , Exequiel Giorgi , Laura Leiva , José María Gutiérrez , Adolfo R. de Roodt , Mauricio de Marzi
{"title":"兔用石线虫毒液和二氧化硅纳米粒子组成的纳米毒液免疫:第一个体内方法","authors":"Federico G. Baudou , María Herrera , Mariángela Vargas , Mauren Villalta , Florencia S. Conti , Exequiel Giorgi , Laura Leiva , José María Gutiérrez , Adolfo R. de Roodt , Mauricio de Marzi","doi":"10.1016/j.toxicon.2025.108462","DOIUrl":null,"url":null,"abstract":"<div><div><em>Dendroaspis polylepis</em> inflicts severe neurotoxic envenomings due to its high content of potent neurotoxins. The poor immunogenicity of these toxins represents a significant challenge in antivenom (AV) generation. Silica nanoparticles (SiNPs) have been proposed for use in medicine due to their ability to stimulate the immune system. This study explored the possible use of SiNPs as adjuvant (ADJ) mixed with <em>D. polylepis</em> venom (nanovenoms, NV) for immunization in rabbits, compared to venom emulsified with the traditional Freund ADJ and with venom alone. ELISA results show that sera from rabbits immunized with NV developed an antibody response similar to sera from rabbits immunized with Freund adjuvant, and did not develop significant lesions at the injection site. Western blot analysis indicates that NV sera group showed a strong recognition of neurotoxins and neutralized a challenge dose of venom (1.5 LD<sub>50</sub>), increasing the survival time of mice. In conclusion, NV proved to be a good ADJ in immunization with <em>D. polylepis</em> venom and could be tested for AV industrial production.</div></div>","PeriodicalId":23289,"journal":{"name":"Toxicon","volume":"264 ","pages":"Article 108462"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Immunization of rabbits with nanovenom composed of Dendroaspis polylepis venom and silica nanoparticles: a first in vivo approach\",\"authors\":\"Federico G. Baudou , María Herrera , Mariángela Vargas , Mauren Villalta , Florencia S. Conti , Exequiel Giorgi , Laura Leiva , José María Gutiérrez , Adolfo R. de Roodt , Mauricio de Marzi\",\"doi\":\"10.1016/j.toxicon.2025.108462\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><em>Dendroaspis polylepis</em> inflicts severe neurotoxic envenomings due to its high content of potent neurotoxins. The poor immunogenicity of these toxins represents a significant challenge in antivenom (AV) generation. Silica nanoparticles (SiNPs) have been proposed for use in medicine due to their ability to stimulate the immune system. This study explored the possible use of SiNPs as adjuvant (ADJ) mixed with <em>D. polylepis</em> venom (nanovenoms, NV) for immunization in rabbits, compared to venom emulsified with the traditional Freund ADJ and with venom alone. ELISA results show that sera from rabbits immunized with NV developed an antibody response similar to sera from rabbits immunized with Freund adjuvant, and did not develop significant lesions at the injection site. Western blot analysis indicates that NV sera group showed a strong recognition of neurotoxins and neutralized a challenge dose of venom (1.5 LD<sub>50</sub>), increasing the survival time of mice. In conclusion, NV proved to be a good ADJ in immunization with <em>D. polylepis</em> venom and could be tested for AV industrial production.</div></div>\",\"PeriodicalId\":23289,\"journal\":{\"name\":\"Toxicon\",\"volume\":\"264 \",\"pages\":\"Article 108462\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Toxicon\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0041010125002375\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicon","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041010125002375","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Immunization of rabbits with nanovenom composed of Dendroaspis polylepis venom and silica nanoparticles: a first in vivo approach
Dendroaspis polylepis inflicts severe neurotoxic envenomings due to its high content of potent neurotoxins. The poor immunogenicity of these toxins represents a significant challenge in antivenom (AV) generation. Silica nanoparticles (SiNPs) have been proposed for use in medicine due to their ability to stimulate the immune system. This study explored the possible use of SiNPs as adjuvant (ADJ) mixed with D. polylepis venom (nanovenoms, NV) for immunization in rabbits, compared to venom emulsified with the traditional Freund ADJ and with venom alone. ELISA results show that sera from rabbits immunized with NV developed an antibody response similar to sera from rabbits immunized with Freund adjuvant, and did not develop significant lesions at the injection site. Western blot analysis indicates that NV sera group showed a strong recognition of neurotoxins and neutralized a challenge dose of venom (1.5 LD50), increasing the survival time of mice. In conclusion, NV proved to be a good ADJ in immunization with D. polylepis venom and could be tested for AV industrial production.
期刊介绍:
Toxicon has an open access mirror Toxicon: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. An introductory offer Toxicon: X - full waiver of the Open Access fee.
Toxicon''s "aims and scope" are to publish:
-articles containing the results of original research on problems related to toxins derived from animals, plants and microorganisms
-papers on novel findings related to the chemical, pharmacological, toxicological, and immunological properties of natural toxins
-molecular biological studies of toxins and other genes from poisonous and venomous organisms that advance understanding of the role or function of toxins
-clinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtained.
-material on the use of toxins as tools in studying biological processes and material on subjects related to venom and antivenom problems.
-articles on the translational application of toxins, for example as drugs and insecticides
-epidemiological studies on envenoming or poisoning, so long as they highlight a previously unrecognised medical problem or provide insight into the prevention or medical treatment of envenoming or poisoning. Retrospective surveys of hospital records, especially those lacking species identification, will not be considered for publication. Properly designed prospective community-based surveys are strongly encouraged.
-articles describing well-known activities of venoms, such as antibacterial, anticancer, and analgesic activities of arachnid venoms, without any attempt to define the mechanism of action or purify the active component, will not be considered for publication in Toxicon.
-review articles on problems related to toxinology.
To encourage the exchange of ideas, sections of the journal may be devoted to Short Communications, Letters to the Editor and activities of the affiliated societies.